JP2022539401A5 - - Google Patents

Info

Publication number
JP2022539401A5
JP2022539401A5 JP2021578069A JP2021578069A JP2022539401A5 JP 2022539401 A5 JP2022539401 A5 JP 2022539401A5 JP 2021578069 A JP2021578069 A JP 2021578069A JP 2021578069 A JP2021578069 A JP 2021578069A JP 2022539401 A5 JP2022539401 A5 JP 2022539401A5
Authority
JP
Japan
Prior art keywords
alkyl
heterocycloalkyl
cycloalkyl
hydrogen
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021578069A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539401A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050933 external-priority patent/WO2021000054A1/en
Publication of JP2022539401A publication Critical patent/JP2022539401A/ja
Publication of JP2022539401A5 publication Critical patent/JP2022539401A5/ja
Ceased legal-status Critical Current

Links

JP2021578069A 2019-07-04 2020-07-03 カンナビノイド誘導体 Ceased JP2022539401A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962870744P 2019-07-04 2019-07-04
US62/870,744 2019-07-04
US201962928838P 2019-10-31 2019-10-31
US62/928,838 2019-10-31
US202062966411P 2020-01-27 2020-01-27
US62/966,411 2020-01-27
PCT/CA2020/050933 WO2021000054A1 (en) 2019-07-04 2020-07-03 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2022539401A JP2022539401A (ja) 2022-09-08
JP2022539401A5 true JP2022539401A5 (cg-RX-API-DMAC10.html) 2025-02-28

Family

ID=74100114

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021578069A Ceased JP2022539401A (ja) 2019-07-04 2020-07-03 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US20220242844A1 (cg-RX-API-DMAC10.html)
EP (1) EP3994129A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022539401A (cg-RX-API-DMAC10.html)
WO (1) WO2021000054A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3994114A4 (en) 2019-07-04 2023-08-16 Canopy Growth Corporation CANNABINOID DERIVATIVES
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation Cannabinoid derivatives
WO2021007661A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12084407B2 (en) 2019-11-26 2024-09-10 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12617765B2 (en) 2019-12-09 2026-05-05 Canopy Growth Corporation Cannabinoid derivatives
IL312785B2 (en) 2020-05-19 2026-06-01 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use
CN113801126A (zh) * 2021-07-20 2021-12-17 云南大学 一种多取代吡啶衍生物及其制备方法
WO2026038872A1 (ko) * 2024-08-13 2026-02-19 주식회사 네오켄바이오 신규한 화합물 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109311838A (zh) * 2016-04-15 2019-02-05 蒂温诺特技术有限公司 大麻素前药的生物合成
EP3840854A4 (en) * 2018-08-20 2022-06-29 Bessor Pharma, LLC Novel cannabinoids and cannabinoid acids and their derivatives

Similar Documents

Publication Publication Date Title
JP2022540432A5 (cg-RX-API-DMAC10.html)
JP2022539400A5 (cg-RX-API-DMAC10.html)
JP2022551067A5 (cg-RX-API-DMAC10.html)
JP2022540585A5 (cg-RX-API-DMAC10.html)
JP2023505513A5 (cg-RX-API-DMAC10.html)
JP2022540433A5 (cg-RX-API-DMAC10.html)
JP2022540586A5 (cg-RX-API-DMAC10.html)
JP2023503331A5 (cg-RX-API-DMAC10.html)
JP2022540434A5 (cg-RX-API-DMAC10.html)
JP2012522793A5 (cg-RX-API-DMAC10.html)
JP2025509088A (ja) Nlrp3の阻害剤
JP2023503330A5 (cg-RX-API-DMAC10.html)
JP2013521264A (ja) ケトベンゾフラン誘導体、その合成方法および中間体
WO2005014525A2 (en) Bi-aryl compound having immunosuppressive activity
JP2013521291A5 (cg-RX-API-DMAC10.html)
JP2015508092A5 (cg-RX-API-DMAC10.html)
JP2023543254A5 (cg-RX-API-DMAC10.html)
JP2022539401A (ja) カンナビノイド誘導体
TW201821406A (zh) Lsd1抑制劑及其用途
JP2011500818A5 (cg-RX-API-DMAC10.html)
JP2010509334A5 (cg-RX-API-DMAC10.html)
JP2015502371A5 (cg-RX-API-DMAC10.html)
JP2023507569A5 (cg-RX-API-DMAC10.html)
PT2279175E (pt) Processo para a preparação de intermediários de naftalen-2- il-pirazol-3-ona úteis na síntese de inibidores de recetores sigma
JP2014509648A5 (cg-RX-API-DMAC10.html)